摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-溴苯基)乙酰胺 | 60312-83-6

中文名称
2-(3-溴苯基)乙酰胺
中文别名
——
英文名称
2-(3-bromophenyl)acetamide
英文别名
——
2-(3-溴苯基)乙酰胺化学式
CAS
60312-83-6
化学式
C8H8BrNO
mdl
——
分子量
214.062
InChiKey
JEYSSRJRKIAJIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    376.9±25.0 °C(Predicted)
  • 密度:
    1.537±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    43.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xi
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302

SDS

SDS:611b9ab8ce021b8119bb32ae2db91f51
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-(3-Bromophenyl)acetamide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-(3-Bromophenyl)acetamide
CAS number: 60312-83-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H8BrNO
Molecular weight: 214.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(3-溴苯基)乙酰胺三乙胺三氟乙酸酐 作用下, 以 1,4-二氧六环 为溶剂, 反应 12.0h, 生成 3-溴氰苄
    参考文献:
    名称:
    5-LIPOXYGENASE INHIBITORS
    摘要:
    本发明涉及5-脂氧酶抑制剂。本文所披露的化合物可用于治疗支气管哮喘、慢性阻塞性肺疾病、关节炎、1型糖尿病、多发性硬化症、移植排斥、银屑病、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒、荨麻疹、特应性皮炎、过敏性鼻炎和其他炎症性和自身免疫性疾病的治疗。本文还提供了所披露化合物的制备方法、含有所披露化合物的制药组合物以及它们作为5-脂氧酶抑制剂的用途。
    公开号:
    US20080021080A1
  • 作为产物:
    描述:
    3-溴氰苄 在 cis-[Mn(2,6-bis(di-tert-butylphosphinomethyl)pyridine)(CO)2] 、 作用下, 以 叔丁醇 为溶剂, 反应 24.0h, 以92%的产率得到2-(3-溴苯基)乙酰胺
    参考文献:
    名称:
    锰-钳-催化腈水合、α-氘化和通过金属配体合作形成α-氘化酰胺
    摘要:
    报道了一种简单有效的系统,用于腈的水合和 α-氘化以形成酰胺、α-氘化腈和 α-氘化酰胺,该系统由能够进行金属-配体合作的地球丰富锰的单钳络合物催化。该反应具有选择性并且可以耐受多种官能团,从而以中等至良好的产率得到相应的酰胺。将溶剂从叔丁醇改为甲苯并使用 D 2 O 导致以高选择性形成 α-氘代腈。此外,可以一步直接从腈和 D 2 中获得 α-氘化酰胺O 在四氢呋喃中。初步的机理研究表明,这些转变通过金属-配体协同途径促进了腈的活化,生成锰酮亚胺和烯酰胺钳络合物作为进一步转变的关键中间体。
    DOI:
    10.1021/acscatal.1c01748
点击查看最新优质反应信息

文献信息

  • 一种含炔基的芳基酰胺类衍生物及其制备方法和应用
    申请人:广东工业大学
    公开号:CN109942616A
    公开(公告)日:2019-06-28
    本发明属于有机合成技术领域,尤其涉及一种含炔基的芳基酰胺类衍生物及其制备方法和应用。本发明提供了一种含炔基的芳基酰胺类衍生物,所述含炔基的芳基酰胺类衍生物的结构式如式(Ⅰ)所示;其中,Ar为芳基,包括芳香杂环基、苯基或芳香稠环基;R1选自氢、卤元素、醚基或含官能团的烃基;R2为氢或烷基;R3为多取代基。本发明芳基酰胺类衍生物引入了具有多功能性的炔基,并且炔基在芳基上位于酰胺基的邻位,鉴于炔基的碳碳三键的丰富的化学活性,以及芳基酰胺在药物中的广泛应用,本发明含炔基的芳基酰胺类衍生物在药物开发中具有良好的应用前景。
  • <scp>Regio‐Divergent</scp> C—H Alkynylation with Janus Directing Strategy <i>via</i> Ir( <scp>III</scp> ) Catalysis
    作者:Xianwei Li、Guangxin Liang、Zhang‐Jie Shi
    DOI:10.1002/cjoc.202000204
    日期:2020.9
    Directing strategy has been extensively exploited to maintain activity and selectivity for the rapid access to functionalized molecules and pharmaceutical targets. However, ‘one‐to‐one’ activation model was usually achieved through traditional directing strategy. Herein, we achieved ‘one‐to‐two’ activation model by slight modification of simple and practical ketoxime and amide functionality. With judicious
    指导策略已得到广泛利用,以保持活性和选择性,以快速获得功能化分子和药物靶标。但是,“一对一”激活模型通常是通过传统的指导策略来实现的。在这里,我们通过对简单而实用的酮和酰胺功能进行一些修改,实现了“一对二”激活模型。通过明智地选择导向基团,实现了Csp 3 -H和Csp 2 -H键的炔基化反应,更重要的是,实现了脱氢的Csp 3 -H炔基化,从而实现了药物在区域上的分散后期修饰。
  • [EN] BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS<br/>[FR] DERIVES DE BENZOFURANE UTILISES POUR TRAITER DES TROUBLES HYPERPROLIFERANTS
    申请人:BAYER PHARMACEUTICALS CORP
    公开号:WO2005014566A1
    公开(公告)日:2005-02-17
    The invention relates to novel heterocycles of formula (I), processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.
    这项发明涉及到式(I)的新异环化合物,以及用于制备这些化合物的方法,以及它们用于制备治疗或预防疾病的药物,特别是治疗过度增殖性疾病的药物。
  • [EN] STRAD-BINDING AGENTS AND USES THEREOF<br/>[FR] AGENTS DE LIAISON À STRAD ET LEURS UTILISATIONS
    申请人:UNIV CALIFORNIA
    公开号:WO2021155004A1
    公开(公告)日:2021-08-05
    Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.
    披露的内容包括,但不限于,用于结合STRAD假激酶的化合物及其用途。
  • [EN] BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS<br/>[FR] DERIVES DE BENZOFURANE ET DE BENZOTHIOPHENE UTILISES DANS LE TRAITEMENT DE TROUBLES HYPERPROLIFERATIFS
    申请人:BAYER PHARMACEUTICALS CORP
    公开号:WO2003072561A1
    公开(公告)日:2003-09-04
    This invention relates to novel benzofuran and benzothiophene derivatives of the general formula and their use for the treatment of hyper-proliferative disorders.
    这项发明涉及一般式的新型苯并呋喃苯并噻吩生物及其用于治疗高增殖性疾病的用途。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫